Details for New Drug Application (NDA): 202052
✉ Email this page to a colleague
The generic ingredient in PANTOPRAZOLE SODIUM is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
Summary for 202052
Tradename: | PANTOPRAZOLE SODIUM |
Applicant: | Orbion Pharms |
Ingredient: | pantoprazole sodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Dec 2, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 40MG BASE | ||||
Approval Date: | Dec 2, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription